UB Paderborn / Katalog / Suche / in CDI

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

The Lancet (British edition), 2011-09, Vol.378 (9796), p.1079-1088

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

BMC cancer, 2021-02, Vol.21 (1), p.117-10, Article 117

2021

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer

Cancer letters, 2019-11, Vol.464, p.5-14

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

ERJ open research, 2018-04, Vol.4 (2), p.120-2017

2018

Link zum Volltext

Verfügbarkeit prüfen

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

Journal of thoracic oncology, 2009-10, Vol.4 (10), p.1280-1288

2009

Link zum Volltext

Verfügbarkeit prüfen

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

Lung cancer (Amsterdam, Netherlands), 2019-11, Vol.137, p.149-156

2019

Link zum Volltext

Verfügbarkeit prüfen

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

The lancet oncology, 2022-09, Vol.23 (9), p.1180-1188

2022

Link zum Volltext

Verfügbarkeit prüfen

Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management

The Annals of thoracic surgery, 2019-04, Vol.107 (4), p.1053-1059

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study)

BMC cancer, 2021-06, Vol.21 (1), p.1-711, Article 711

2021

Link zum Volltext

Verfügbarkeit prüfen

Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study

Cancers, 2022-08, Vol.14 (16), p.3878

2022

Link zum Volltext

Verfügbarkeit prüfen

Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study)

International journal of environmental research and public health, 2022-12, Vol.19 (23), p.16246

2022

Link zum Volltext

Verfügbarkeit prüfen

Thymic metastasis from lung carcinoma

Interactive cardiovascular and thoracic surgery, 2011-05, Vol.12 (5), p.848-849

2011

Link zum Volltext

Verfügbarkeit prüfen

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

The European respiratory journal, 2015-05, Vol.45 (5), p.1403-1414

2015

Link zum Volltext

Verfügbarkeit prüfen

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

Targeted oncology, 2022-11, Vol.17 (6), p.675-682

2022

Link zum Volltext

Verfügbarkeit prüfen

Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

Cancer letters, 2019-03, Vol.444, p.147-161

2019

Link zum Volltext

Verfügbarkeit prüfen

Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib

Oncotarget, 2014-09, Vol.5 (18), p.8252-8269

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients

European journal of cancer (1990), 2016-01, Vol.52, p.120-128

2016

Link zum Volltext

Verfügbarkeit prüfen

Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank

BMC public health, 2017-04, Vol.17 (1), p.324-324, Article 324

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

BMC cancer, 2021-12, Vol.21 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Frontiers in endocrinology (Lausanne), 2013, Vol.3, p.184

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of extracranial stereotactic body radiation therapy

BMC cancer, 2021-02, Vol.21 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/ IFCT-1002

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management

Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study)

Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study

Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study)

Thymic metastasis from lung carcinoma

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients

Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Efficacy of extracranial stereotactic body radiation therapy

Suchergebnisse filtern